Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs, …

Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid,
rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to …

A 44-year-old man who recently immigrated from Peru is found to have induration of 16 mm
on a tuberculin skin test. He received bacille Calmette–Guérin vaccine as an infant and is …

The American Thoracic Society, Centers for Disease Control and Prevention, and Infectious
Diseases Society of America jointly sponsored the development of this guideline for the …

Global tuberculosis incidence has declined marginally over the past decade, and tuberculosis
remains out of control in several parts of the world including Africa and Asia. Although …

This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …

Background Rifapentine-based regimens have potent antimycobacterial activity that may allow
for a shorter course in patients with drug-susceptible pulmonary tuberculosis. Methods In …

Background: The American Thoracic Society, US Centers for Disease Control and
Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly …

Background Incomplete adherence to tuberculosis (TB) treatment increases the risk of
delayed culture conversion with continued transmission in the community, as well as treatment …

Two decades ago, WHO declared tuberculosis a global emergency, and invested in the highly
cost-effective directly observed treatment short-course programme to control the epidemic…